6-3850772-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_012135.3(FAM50B):āc.961A>Gā(p.Lys321Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000428 in 1,613,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000039 ( 0 hom., cov: 33)
Exomes š: 0.000043 ( 0 hom. )
Consequence
FAM50B
NM_012135.3 missense
NM_012135.3 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 3.66
Genes affected
FAM50B (HGNC:18789): (family with sequence similarity 50 member B) This gene contains an intronless ORF that arose from ancestral retroposition. The encoded protein is related to a plant protein that plays a role in the circadian clock. This gene is adjacent to a differentially methylated region (DMR) and is imprinted and paternally expressed in many tissues. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28105342).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM50B | NM_012135.3 | c.961A>G | p.Lys321Glu | missense_variant | 2/2 | ENST00000648326.1 | NP_036267.1 | |
FAM50B | XM_017010729.2 | c.961A>G | p.Lys321Glu | missense_variant | 2/2 | XP_016866218.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM50B | ENST00000648326.1 | c.961A>G | p.Lys321Glu | missense_variant | 2/2 | NM_012135.3 | ENSP00000496837.1 | |||
FAM50B | ENST00000380274.2 | c.961A>G | p.Lys321Glu | missense_variant | 1/1 | 6 | ENSP00000369627.1 | |||
ENSG00000238158 | ENST00000454396.2 | n.80-4698A>G | intron_variant | 5 | ||||||
ENSG00000233068 | ENST00000648025.1 | n.76+18761A>G | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152054Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
152054
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000678 AC: 17AN: 250628Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135664
GnomAD3 exomes
AF:
AC:
17
AN:
250628
Hom.:
AF XY:
AC XY:
11
AN XY:
135664
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000431 AC: 63AN: 1461546Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 28AN XY: 727098
GnomAD4 exome
AF:
AC:
63
AN:
1461546
Hom.:
Cov.:
31
AF XY:
AC XY:
28
AN XY:
727098
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152054Hom.: 0 Cov.: 33 AF XY: 0.0000539 AC XY: 4AN XY: 74260
GnomAD4 genome
AF:
AC:
6
AN:
152054
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74260
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2022 | The c.961A>G (p.K321E) alteration is located in exon 2 (coding exon 1) of the FAM50B gene. This alteration results from a A to G substitution at nucleotide position 961, causing the lysine (K) at amino acid position 321 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;D
REVEL
Benign
Sift
Uncertain
.;D;D
Sift4G
Benign
.;T;T
Polyphen
P;P;P
Vest4
0.29, 0.30
MutPred
Loss of MoRF binding (P = 0);Loss of MoRF binding (P = 0);Loss of MoRF binding (P = 0);
MVP
0.38
MPC
1.4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at